Oasis Diagnostics
Oasis Diagnostics® Corporation is an emerging Company focused on two core areas of the in vitro diagnostic market - saliva based diagnostics and genomics. Over the past eight years the Company has assembled a portfolio of proprietary devices and tools for the standardized collection of saliva, immediate disease testing from saliva and the collection of DNA from saliva specimens. Oasis' non-invasive collection and testing technologies address the three main segments of the IVD market- molecular diagnostics, rapid, point-of-care testing and diagnostics performed in the laboratory, and may be applied to a variety of areas including infectious diseases [including tuberculosis and HIV], steroid hormones for general wellness, oncology, immune response, cardiovascular disease and many others.
About Oasis Diagnostics
Founded
2002Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$733KCategory
Industry
BiotechnologyLocation
City
VancouverState
WashingtonCountry
United StatesOasis Diagnostics
Find your buyer within Oasis Diagnostics